Which herbal product has been linked to rare liver injury and is often avoided in OTC products?

Prepare effectively for the Over-the-Counter Drugs, Herbal Supplements, Vitamins, and Minerals Test. Engage with detailed flashcards and interactive multiple-choice questions, accompanied by informative hints and explanations. Get exam-ready with confidence!

Multiple Choice

Which herbal product has been linked to rare liver injury and is often avoided in OTC products?

Explanation:
Liver safety is a major consideration when evaluating herbal products for OTC use. Kava has been linked to rare but serious liver injury, including hepatitis and liver failure in some cases. Because of these reports, regulators and manufacturers have moved away from including Kava in OTC products, and many warnings or restrictions exist around its use. The potential for significant liver harm means it’s avoided in standard OTC formulations, especially for people with preexisting liver issues or those who consume alcohol. Other herbs listed here have different safety concerns. Echinacea isn’t strongly associated with liver injury, St. John’s wort is mainly noted for drug interactions, and valerian is used for sleep with a safety profile that doesn’t carry the same level of liver risk that has led to Kava’s avoidance.

Liver safety is a major consideration when evaluating herbal products for OTC use. Kava has been linked to rare but serious liver injury, including hepatitis and liver failure in some cases. Because of these reports, regulators and manufacturers have moved away from including Kava in OTC products, and many warnings or restrictions exist around its use. The potential for significant liver harm means it’s avoided in standard OTC formulations, especially for people with preexisting liver issues or those who consume alcohol.

Other herbs listed here have different safety concerns. Echinacea isn’t strongly associated with liver injury, St. John’s wort is mainly noted for drug interactions, and valerian is used for sleep with a safety profile that doesn’t carry the same level of liver risk that has led to Kava’s avoidance.

More practice questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy